{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:30:46Z","timestamp":1761823846333,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cirug\u00eda Ortop\u00e9dica y Traumatolog\u00eda"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.recot.2013.12.001","type":"journal-article","created":{"date-parts":[[2014,4,13]],"date-time":"2014-04-13T23:15:20Z","timestamp":1397430920000},"page":"171-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Novedades en displasias \u00f3seas"],"prefix":"10.1016","volume":"58","author":[{"given":"E.","family":"Borrego","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.M.","family":"Farrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.J.","family":"Downey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.recot.2013.12.001_bib0005","series-title":"Children's orthopaedics and fractures","first-page":"75","article-title":"Bone, cartilage and fibrous tissue disorders","author":"Cole","year":"2010"},{"key":"10.1016\/j.recot.2013.12.001_bib0010","series-title":"Lovell & Winter's pediatric orthopaedics","first-page":"206","article-title":"The skeletal dysplasias","author":"Sponseller","year":"2006"},{"key":"10.1016\/j.recot.2013.12.001_bib0015","series-title":"Pediatric orthopedics in practice","first-page":"645","article-title":"Hereditary diseases","author":"Hefti","year":"2007"},{"key":"10.1016\/j.recot.2013.12.001_bib0020","series-title":"Tratado de Pediatr\u00eda","first-page":"2501","article-title":"Displasias esquel\u00e9ticas","author":"Horton","year":"2011"},{"key":"10.1016\/j.recot.2013.12.001_bib0025","series-title":"Cirug\u00eda Ortop\u00e9dica y Traumatolog\u00eda","article-title":"Displasias \u00f3seas","author":"Villalba","year":"2012"},{"issue":"Suppl 3","key":"10.1016\/j.recot.2013.12.001_bib0030","first-page":"60","article-title":"Molecular basis for the treatment of achondroplasia","volume":"60","author":"Yamanaka","year":"2003","journal-title":"Horm Res"},{"key":"10.1016\/j.recot.2013.12.001_bib0035","first-page":"238","article-title":"Limb lengthening in short stature patients","volume":"10","author":"Aldegheri","year":"2001","journal-title":"J Pediatr Orthop B"},{"key":"10.1016\/j.recot.2013.12.001_bib0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00547160","article-title":"Limb lengthening in achondroplasia by Ilizarov's method","volume":"12","author":"Cattaneo","year":"1988","journal-title":"Int Orthop"},{"key":"10.1016\/j.recot.2013.12.001_bib0045","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00003086-199001000-00016","article-title":"Psychologic, vascular, and physiologic aspects of lower limb lengthening in achondroplastics","volume":"250","author":"Lavini","year":"1990","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.recot.2013.12.001_bib0050","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s11999-011-1983-y","article-title":"Is bilateral lower limb lenghtening appropriate for achondroplasia?","volume":"470","author":"Seung-Ju","year":"2012","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.recot.2013.12.001_bib0055","unstructured":"Little People of America. Acondroplasia. Historia natural en el infante y ni\u00f1o [consultado 2 Feb 2013]. Disponible en: http:\/\/www.lpaonline.org\/assets\/documents\/NH_Spanish_achondroplasia_final_y_revisada-ESP.pdf"},{"key":"10.1016\/j.recot.2013.12.001_bib0060","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/MOP.0b013e32833b7a69","article-title":"Achondroplasia: Pathogenesis and implications for future treatment","volume":"22","author":"Laederich","year":"2010","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.recot.2013.12.001_bib0065","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2174\/1389450033490993","article-title":"Fibroblast growth factor receptor-3 as a therapeutic target for Achondroplasia- genetic short limbed dwarfism","volume":"4","author":"Aviezer","year":"2003","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.recot.2013.12.001_bib0070","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejca.2008.10.013","article-title":"Current perspective- trastuzumab","volume":"45","author":"Hall","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.recot.2013.12.001_bib0075","doi-asserted-by":"crossref","first-page":"38194","DOI":"10.1074\/jbc.M303164200","article-title":"Human combinatorial Fab library yielding specific and functional antibodies against the human fibroblast growth factor receptor 3","volume":"278","author":"Rauchenberger","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.recot.2013.12.001_bib0080","doi-asserted-by":"crossref","first-page":"E1339","DOI":"10.1152\/ajpendo.00272.2009","article-title":"Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice","volume":"297","author":"Kake","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.recot.2013.12.001_bib0085","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1210\/en.2008-1676","article-title":"Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal displasias","volume":"150","author":"Yasoda","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.recot.2013.12.001_bib0090","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1177\/0091270009336233","article-title":"Pharmacodynamics of a novel designer natriuretic peptide, CD-NP, in a first-in-human clinical trial in healthysubjects","volume":"49","author":"Lee","year":"2009","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.recot.2013.12.001_bib0095","series-title":"Lecciones de cirug\u00eda ortop\u00e9dica y traumatolog\u00eda","first-page":"19","article-title":"Displasias \u00f3seas de inter\u00e9s ortop\u00e9dico","author":"Ferr\u00e1ndez","year":"2005"},{"key":"10.1016\/j.recot.2013.12.001_bib0100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jmg.16.2.101","article-title":"Genetic heterogeneity in osteogenesis imperfect","volume":"16","author":"Sillence","year":"1979","journal-title":"J Med Genet"},{"key":"10.1016\/j.recot.2013.12.001_bib0105","first-page":"302","article-title":"Aplicaciones de los bifosfonatos en la ortopedia infantil","volume":"55","author":"Salom","year":"2011","journal-title":"Rev Esp Cir Ortop Traumatol"},{"key":"10.1016\/j.recot.2013.12.001_bib0110","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00223-008-9211-9","article-title":"Intravenous pamidronate in osteogneesis imperfect type viii","volume":"84","author":"Cheung","year":"2009","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.recot.2013.12.001_bib0115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1515\/JPEM.2008.21.1.63","article-title":"Cyclic pamidronat therapy in children with osteogenesis imperfecta: Results of treatment and follow-up after discontinuation","volume":"21","author":"Andiran","year":"2008","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.recot.2013.12.001_bib0120","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1651-2227.2010.01968.x","article-title":"Biochemical bone markers in the assessement and pamidronat treatment of children with osteogenesis imperfect","volume":"99","author":"Astr\u00f6m","year":"2010","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.recot.2013.12.001_bib0125","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.bone.2004.07.003","article-title":"Intravenous pamidronate treatment of children under 36 months age with osteogenesis imperfecta","volume":"35","author":"Di Meglio","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.recot.2013.12.001_bib0130","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1359\/JBMR.050213","article-title":"Effects of intravenous pamidronate treatment in infants with osteogenesis imperfect: Clinical and histomorphometric outcome","volume":"20","author":"Munns","year":"2005","journal-title":"J Bone Min Res"},{"issue":"Suppl 2","key":"10.1016\/j.recot.2013.12.001_bib0135","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1542\/peds.2006-2023I","article-title":"Experience with bisphosphonates in osteogenesis imperfecta","volume":"119","author":"Glorieux","year":"2007","journal-title":"Paediatrics"},{"key":"10.1016\/j.recot.2013.12.001_bib0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1469-8749.2008.03222.x","article-title":"Effects of bisphosphonates in children with osteogenesis imperfect: An AACPDM systematic review","volume":"51","author":"Castillo","year":"2008","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.recot.2013.12.001_bib0145","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/BPO.0b013e318173a923","article-title":"Successful results of pamidronate treatment in children with osteogenesis imperfect with emphasis on the interpretation of bone mineral density for local standars","volume":"28","author":"Poyrazoglu","year":"2008","journal-title":"J Pediatr Orthop"},{"key":"10.1016\/j.recot.2013.12.001_bib0150","first-page":"CD005088","article-title":"Biphosphonate therapy for osteogenesis imperfecta","volume":"4","author":"Phillipi","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.recot.2013.12.001_bib0155","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11832-011-0380-0","article-title":"Changing pattern of femoral fractures in osteogenesis imperfecta with prolonged use of biphosphonates","volume":"6","author":"Nicolau","year":"2012","journal-title":"J Child Orthop"},{"key":"10.1016\/j.recot.2013.12.001_bib0160","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1302\/0301-620X.93B10.26924","article-title":"Long-term bisphosphonate usage and subtrochanteric insufficiency fractures: A cause for concern?","volume":"93","author":"Yoon","year":"2011","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.recot.2013.12.001_bib0165","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1302\/0301-620X.89B3.18146","article-title":"Subtrochanteric insufficiency fractures in patients on alendronate therapy: A caution","volume":"89","author":"Goh","year":"2007","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.recot.2013.12.001_bib0170","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.injury.2007.08.036","article-title":"An emerging pattern of subtrochanteric stress fractures: A long-term complication of alendronate therapy?","volume":"39","author":"Kwek","year":"2008","journal-title":"Injury"},{"key":"10.1016\/j.recot.2013.12.001_bib0175","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1302\/0301-620X.92B5.22941","article-title":"A rational approach to management of alendronate-related subtrochanteric fractures","volume":"92","author":"De Das","year":"2010","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.recot.2013.12.001_bib0180","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1185\/03007995.2011.580341","article-title":"Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: the Japanese Osteoporosis Intervention Trial (JOINT)-02","volume":"27","author":"Orimo","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.recot.2013.12.001_bib0185","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00296-006-0288-z","article-title":"Superiority of a combined treatment of alendronate and alfacalcidol compared to the combination of alendronate and plain vitamin D or alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial)","volume":"27","author":"Ringe","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.recot.2013.12.001_bib0190","first-page":"1","article-title":"Eleven years of experience with biphosphonate plus alfacalcidol treatment in a man with osteogenesis imperfecta type i","volume":"9","author":"Iwamoto","year":"2013","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.recot.2013.12.001_bib0195","first-page":"e29","article-title":"The influence of ibandronate treatment on bone density and biochemical bone markers in patients with osteogenesis imperfecta","volume":"4","author":"Ingmar","year":"2012","journal-title":"Orthop Rev"},{"key":"10.1016\/j.recot.2013.12.001_bib0200","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.recot.2013.12.001_bib0205","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11914-010-0034-z","article-title":"Denosumab for the treatment of osteoporosis","volume":"8","author":"Iqbal","year":"2010","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.recot.2013.12.001_bib0210","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1359\/jbmr.090716","article-title":"Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy","volume":"25","author":"Kendler","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.recot.2013.12.001_bib0215","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2165\/11594240-000000000-00000","article-title":"Population pharmacokinetic meta-analysis of denosumab in healthy subjects and postmenopausal women with osteopenia or osteoporosis","volume":"50","author":"Sutjandra","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.recot.2013.12.001_bib0220","first-page":"183","article-title":"First use of the RANKL antibody denosumab in osteogenesis imperfecta type vi","volume":"12","author":"Semler","year":"2012","journal-title":"J Musculoskelet Neuronal Interact"}],"container-title":["Revista Espa\u00f1ola de Cirug\u00eda Ortop\u00e9dica y Traumatolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1888441514000022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1888441514000022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:18:17Z","timestamp":1761823097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1888441514000022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S1888441514000022"],"URL":"https:\/\/doi.org\/10.1016\/j.recot.2013.12.001","relation":{},"ISSN":["1888-4415"],"issn-type":[{"type":"print","value":"1888-4415"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novedades en displasias \u00f3seas","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cirug\u00eda Ortop\u00e9dica y Traumatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.recot.2013.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 SECOT. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}